 Added 19,367 New Subscribers in 4Q21 Revenues Up 0.8 YoY to RMB302.3 million 46.1 million Net Income Attributable Up 31.7 YoY to RMB127.7 million 19.5 million Operating Cash Flow Up 134.6 YoY to RMB211.1 million 32.2 million Conference Call to be Held on June 29, 2021 at 8:00 a.m. ET HONG KONG, June 28, 2021 PRNewswire -- Global Cord Blood Corporation NYSE: CO GCBC or the Company, Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the fourth quarter and full year of fiscal 2021, ended March 31, 2021. 